[go: up one dir, main page]

AU2003900505A0 - Anthelmintic composition - Google Patents

Anthelmintic composition

Info

Publication number
AU2003900505A0
AU2003900505A0 AU2003900505A AU2003900505A AU2003900505A0 AU 2003900505 A0 AU2003900505 A0 AU 2003900505A0 AU 2003900505 A AU2003900505 A AU 2003900505A AU 2003900505 A AU2003900505 A AU 2003900505A AU 2003900505 A0 AU2003900505 A0 AU 2003900505A0
Authority
AU
Australia
Prior art keywords
anthelmintic composition
anthelmintic
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003900505A
Inventor
Brian Desmond Ford
Marcus Holdsworth
Kai Kin Lau
John James O'brien
Edward Lionel Bruce Whittem
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jurox Pty Ltd
Original Assignee
Jurox Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=30005205&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2003900505(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Jurox Pty Ltd filed Critical Jurox Pty Ltd
Priority to AU2003900505A priority Critical patent/AU2003900505A0/en
Publication of AU2003900505A0 publication Critical patent/AU2003900505A0/en
Priority to PCT/AU2004/000126 priority patent/WO2004069242A1/en
Priority to BRPI0407271A priority patent/BRPI0407271B1/en
Priority to AU2004210461A priority patent/AU2004210461C1/en
Priority to NZ540391A priority patent/NZ540391A/en
Priority to GB0516881A priority patent/GB2413764B8/en
Priority to ARP040100372A priority patent/AR043044A1/en
Priority to AU2009201942A priority patent/AU2009201942C1/en
Priority to AU2012200544A priority patent/AU2012200544C1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/275Nitriles; Isonitriles
    • A61K31/277Nitriles; Isonitriles having a ring, e.g. verapamil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017Non-human animal skin, e.g. pour-on, spot-on
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41681,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41841,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AU2003900505A 2003-02-05 2003-02-05 Anthelmintic composition Abandoned AU2003900505A0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
AU2003900505A AU2003900505A0 (en) 2003-02-05 2003-02-05 Anthelmintic composition
GB0516881A GB2413764B8 (en) 2003-02-05 2004-02-04 Anthelmintic compostion
NZ540391A NZ540391A (en) 2003-02-05 2004-02-04 Anthelmintic composition
AU2004210461A AU2004210461C1 (en) 2003-02-05 2004-02-04 Anthelmintic composition
BRPI0407271A BRPI0407271B1 (en) 2003-02-05 2004-02-04 anthelmintic composition
PCT/AU2004/000126 WO2004069242A1 (en) 2003-02-05 2004-02-04 Anthelmintic composition
ARP040100372A AR043044A1 (en) 2003-02-05 2004-02-05 ANTIHELMINTIC COMPOSITION
AU2009201942A AU2009201942C1 (en) 2003-02-05 2009-05-15 Anthelmintic composition
AU2012200544A AU2012200544C1 (en) 2003-02-05 2012-01-31 Anthelmintic composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU2003900505A AU2003900505A0 (en) 2003-02-05 2003-02-05 Anthelmintic composition

Publications (1)

Publication Number Publication Date
AU2003900505A0 true AU2003900505A0 (en) 2003-02-20

Family

ID=30005205

Family Applications (3)

Application Number Title Priority Date Filing Date
AU2003900505A Abandoned AU2003900505A0 (en) 2003-02-05 2003-02-05 Anthelmintic composition
AU2004210461A Expired AU2004210461C1 (en) 2003-02-05 2004-02-04 Anthelmintic composition
AU2009201942A Expired AU2009201942C1 (en) 2003-02-05 2009-05-15 Anthelmintic composition

Family Applications After (2)

Application Number Title Priority Date Filing Date
AU2004210461A Expired AU2004210461C1 (en) 2003-02-05 2004-02-04 Anthelmintic composition
AU2009201942A Expired AU2009201942C1 (en) 2003-02-05 2009-05-15 Anthelmintic composition

Country Status (6)

Country Link
AR (1) AR043044A1 (en)
AU (3) AU2003900505A0 (en)
BR (1) BRPI0407271B1 (en)
GB (1) GB2413764B8 (en)
NZ (1) NZ540391A (en)
WO (1) WO2004069242A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0316377D0 (en) 2003-07-12 2003-08-13 Norbrook Lab Ltd Parasiticidal composition
CN101686962B (en) * 2007-06-29 2012-05-23 辉瑞大药厂 Combination of anthelmintics
AU2008324095A1 (en) * 2007-11-09 2009-05-14 Intervet International B.V. Anthelmintic combination
AU2010100349B4 (en) * 2009-04-15 2012-03-29 Jurox Pty Ltd Anthelmintic formulation
CA3040719C (en) * 2009-09-07 2022-06-14 Argenta Innovation Limited Granulated anthelmintic preparations and delivery systems
AR081187A1 (en) * 2010-05-12 2012-07-04 Merial Ltd INJECTABLE FORMULATIONS PARASITICIDES OF LEVAMISOL AND MACROCICLIC LACTONS. PREPARATION METHOD. TREATMENT METHOD
PE20141179A1 (en) 2011-06-23 2014-10-11 Bayer New Zealand Ltd AN ANTIPARASITIC COMPOSITION AND METHOD OF TREATMENT
NZ594610A (en) 2011-08-16 2013-03-28 Virbac New Zealand Ltd Injectable Anthelmintic Formulations cotaining levamisole and one or more macrocyclic lactones for controlling internal parasites in ruminants
WO2018038623A1 (en) * 2016-08-23 2018-03-01 Donaghys Limited Improvements in parasite treatments

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6340672B1 (en) * 2000-02-16 2002-01-22 Phoenix Scientific, Inc. Parasiticidal formulation and a method of making this formulation

Also Published As

Publication number Publication date
AU2009201942A1 (en) 2009-06-04
BRPI0407271A (en) 2006-01-31
WO2004069242A1 (en) 2004-08-19
BRPI0407271B1 (en) 2015-11-10
GB2413764B8 (en) 2013-10-16
AU2004210461A1 (en) 2004-08-19
GB0516881D0 (en) 2005-09-28
AR043044A1 (en) 2005-07-13
GB2413764B (en) 2006-12-20
GB2413764A8 (en) 2013-10-16
AU2004210461B2 (en) 2009-12-03
AU2009201942B2 (en) 2012-02-16
GB2413764A (en) 2005-11-09
AU2004210461C1 (en) 2017-06-29
NZ540391A (en) 2006-12-22
AU2009201942C1 (en) 2017-06-29

Similar Documents

Publication Publication Date Title
AU2003224597A1 (en) Organic compositions
AU2003285288A1 (en) Composition
AU2003304507A1 (en) Anti-coronavirus agent
AU2003300056A1 (en) Organic compositions
AU2002950744A0 (en) Composition
AU2003235708A1 (en) Polytartrate composition
AU2003208411A1 (en) Anti-glycolytic composition
AU2003269904A1 (en) Antigen-polymer compositions
AU2003900505A0 (en) Anthelmintic composition
AU2002338201A1 (en) Anthelmintic composition
AU2003202905A1 (en) Organic composition
AU2003902430A0 (en) Masterbatch composition
AU2003100144A4 (en) Lousicide composition
AU2003275963A1 (en) Polymer composition
AU2003208841A1 (en) Gasolinen compositions
AU2003268772A1 (en) Oil-barrier composition
AU2003216382A1 (en) Idothyronine compositions
AU2003218497A1 (en) FACTORVIIa COMPOSITIONS
AU2003903763A0 (en) Composition
AU2003280821A1 (en) Beauveriolide derivative
HK1089377A (en) Pharmaceutical composition
HK1088245A (en) Pharmaceutical composition
AU2003902322A0 (en) Pharmaceutical composition
AU2003266526A1 (en) Medicinal composition
HK1092702A (en) Pharmaceutical compositions